Archives

• December 2008

  

• October/November 2008

  Feature Story Elective PCI Without On-Site Cardiac Surgery: Standard of Care? By Gregory J. Dehmer, MD

• September 2008

  Feature Story Xience V (Promus) Drug-Eluting Coronary Stent By Krishna Sudhir, MD, PhD, FRACP, FACC; David R. Rutledge, Pharm D, FAHA, FCCP; Alena Pechonkina, MD; and Chuck Simonton, MD, FACC, FSCAI

• July/August 2008

  Feature Story Physiologic Lesion Assessment By William F. Fearon, MD

• May/June 2008

  Feature Story Percutaneous Aortic Valve Replacement By Eberhard Grube, MD, and Dinesh Nair, MD

• April 2008

  Feature Story Indications for CABG in the DES Era By Michael Mack, MD

• March 2008

  Feature Story 2007 Focused Update of the ACC/AHA Guidelines By Eric R. Bates, MD

• January/February 2008

  Feature Story Prediction of Risk and Complications By David R. Holmes, Jr, MD, and Mandeep Singh, MD

TOP 5 ARTICLES FROM 2008

• Xience V (Promus) Drug-Eluting Coronary Stent

  Design features, preclinical data, and clinical outcomes.

  By Krishna Sudhir, MD, PhD, FRACP, FACC; David R. Rutledge, Pharm D, FAHA, FCCP; Alena Pechonkina, MD; and Chuck Simonton, MD, FACC, FSCAI

• Stent Pipeline

  An update on absorbable polymers and stents.

  By Alexandre Abizaid, MD, PhD; Andre Lima Brito, MD; and J. Ribamar Costa Jr, MD

• Atrial Transseptal Puncture Techniques

  Atrial transseptal puncture is increasingly important for cardiac interventions and has undergone recent technical advances.

  By T.R.D. Shaw, MD, FRCP, FESC

• Percutaneous Aortic Valve Replacement

  An update on the current state of the Sapien percutaneous aortic valve.

  By Augusto Pichard, MD, and Lowell Satler, MD

• 2008 FDA Guidelines for DES

  The how and why of FDA oversight of drug-eluting stents.

  By Andrew Farb, MD, and Ashley B. Boam, MS